Which Vaccine Stocks Will Make You a Fortune in 2022?
For example, Novavax (NASDAQ: NVAX) soared 2,700% in 2020. Of course, it's impossible to predict with 100% certainty which companies will succeed in the vaccine race -- and whether their share prices will skyrocket. Gritstone Bio (NASDAQ: GRTS) is developing an mRNA vaccine candidate.